đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The primary objective of the the trial is to establish one of three study a...
Status
Unknown
Location
Aalborg University Hospital, Dept of Hematology
Start Date
2016-07
Trial ID
NCT02858258
Treatments Being Tested
The current standard of care for the frontline treatment of peripheral T-ce...
Status
Terminated
Location
Brigham and Women's Hospital
Start Date
2013-07
Trial ID
NCT01746173
To test the superiority of VCAP-AMP-VECP regimen over biweekly-CHOP in aggr...
Status
Completed
Location
Nagasaki University Graduate School of Biomedical Science
Start Date
1998-08
Trial ID
NCT00145002
This study is a phase III, randomized, open-label, international, multicent...
Status
Recruiting
Location
Krankenhaus der Barmherzigen BrĂŒder Graz - Abteilung FĂŒr Innere Medizin I
Start Date
2024-06-07
Trial ID
NCT06284122
The study has the purpose to compare R-CHOP versus R-mini-CEOP in elderly p...
Status
Completed
Location
S.C. di Ematologia, Spedali Civili
Start Date
2003-01
Trial ID
NCT01148446
The study aims to compare two application forms (pre-filled syringe and On-...
Status
Completed
Location
Research Site
Start Date
2018-06-25
Trial ID
NCT03619993
Treatments Being Tested
This is a phase â Ą study of erythropoietin for management of anemia caused b...
Status
Completed
Location
Multiple Locations
Start Date
2012-09-01
Trial ID
NCT02890602
Treatments Being Tested
We now propose to investigate the combination of CHOP-Rituxan plus PEG-Filg...
Status
Completed
Location
Hospital Auxilio Mutuo Cancer Center
Start Date
2006-01
Trial ID
NCT01527422
Treatments Being Tested
This is a prospective, multicenter, single arm, phase II trial in young pat...
Status
Terminated
Location
IRCCS Candiolo - Fondazione del Piemonte per l'oncologia
Start Date
2016-09
Trial ID
NCT02670317
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Rigshospitalet, Department of Hematology
Start Date
2006-01-02
Trial ID
NCT00278408